Identification | Back Directory | [Name]
6-Amino-2,3-dibromopyridine | [CAS]
89284-11-7 | [Synonyms]
5,6-Dibromo-2-pyridinamine 6-Amino-2,3-dibromopyridine 2-Pyridinamine, 5,6-dibromo- 5,6-DibroMo-pyridin-2-ylaMine 5,6-Dibromo-2-pyridinamine 97% | [Molecular Formula]
C5H4Br2N2 | [MDL Number]
MFCD00234045 | [MOL File]
89284-11-7.mol | [Molecular Weight]
251.91 |
Chemical Properties | Back Directory | [Melting point ]
154-155 °C(Solv: benzene (71-43-2)) | [Boiling point ]
298.1±35.0 °C(Predicted) | [density ]
2.147±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [pka]
1.19±0.10(Predicted) | [Appearance]
White to light brown Solid | [InChI]
InChI=1S/C5H4Br2N2/c6-3-1-2-4(8)9-5(3)7/h1-2H,(H2,8,9) | [InChIKey]
SETWFMYLBKUBKF-UHFFFAOYSA-N | [SMILES]
C1(N)=NC(Br)=C(Br)C=C1 |
Hazard Information | Back Directory | [Synthesis]
Under argon protection, 6-bromopyridin-2-amine (5 g, 28.90 mmol) was dissolved in DMF (75 mL) and stirred at 0 °C. To this solution, N-bromosuccinimide (35 mg, 1.04 mmol) was slowly added. The reaction mixture was gradually warmed up to room temperature and stirred continuously for 16 hours. The progress of the reaction was monitored by TLC and after confirming complete consumption of the feedstock, the reaction was quenched with ice-cold water (50 mL). Subsequently, the reaction mixture was extracted with EtOAc (2 x 50 mL). The organic phases were combined, dried with anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography (eluent: 30% EtOAc/hexane) to afford 5,6-dibromopyridin-2-amine (6.1 g, 85% yield) as an off-white solid. The structure of the product was confirmed by 1H-NMR (CDCl3, 400 MHz) and LCMS: 1H-NMR δ 7.51 (d, 1H), 6.32 (d, 1H), 4.60 (br s, 2H); LCMS m/z 252.6 (M + 1); Chromatographic conditions: X-Select CSH C-18 column (50×3.0 mm, 3.5 μm ), mobile phase 0.05% trifluoroacetic acid aqueous solution/acetonitrile, flow rate 0.80 mL/min, retention time 3.04 min. | [References]
[1] Patent: CN107778302, 2018, A. Location in patent: Paragraph 0101-0103 [2] Patent: WO2005/100353, 2005, A1. Location in patent: Page/Page column 21 [3] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 5, p. 1697 - 1700 [4] Patent: WO2015/109109, 2015, A1. Location in patent: Paragraph 0710 [5] Patent: US2017/44182, 2017, A1. Location in patent: Paragraph 0982 |
|
|